Merz Korea signs business agreement of ‘Contractubex’ with C&C Healthcare

Published: 2017-05-16 13:37:56

Updated: 2017-05-16 13:42:25

Follow by the business agreement for ‘Pantogar’ last March, Merz Korea is newly launching an OTC drug business by selecting a new partner for ‘Contractubex,’ a scar treatment.

Merz Korea(CEO Soo-Yeon Yoo), a German pharmaceutical company specializing in aesthetics, signed an business agreement for ‘Contractubex’ at its headquarters with C&C Healthcare(CEO Jung-Jo Yoo) on the 15^th.

C&C Healthc...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.